Evidence map›Paper›PMID 35008176›Full record

ArticleCancers2021

Immune-Proteome Profiling in Classical Hodgkin Lymphoma Tumor Diagnostic Tissue.

Alex Reza Gholiha, Peter Hollander, Liza Löf, Anders Larsson, Jamileh Hashemi, Johan Mattsson Ulfstedt, Daniel Molin, Rose-Marie Amini, Eva Freyhult, Masood Kamali-Moghaddam and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Alex Reza GholihaExperimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, SE-752 36 Uppsala, Sweden.ORCID 0000-0002-3393-1106
Peter HollanderClinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University, SE-752 36 Uppsala, Sweden.ORCID 0000-0002-0226-5681
Liza LöfDepartment of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, SE-751 08 Uppsala, Sweden.
Anders LarssonDepartment of Medical Sciences, Clinical Chemistry, Uppsala University, SE-751 85 Uppsala, Sweden.ORCID 0000-0003-3161-0402
Jamileh HashemiExperimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, SE-752 36 Uppsala, Sweden.
Johan Mattsson UlfstedtExperimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, SE-752 36 Uppsala, Sweden.ORCID 0000-0003-0682-7394
Daniel MolinExperimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, SE-752 36 Uppsala, Sweden.
Rose-Marie AminiClinical and Experimental Pathology, Department of Immunology, Genetics and Pathology, Uppsala University, SE-752 36 Uppsala, Sweden.
Eva FreyhultDepartment of Cell and Molecular Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, SE-752 36 Uppsala, Sweden.ORCID 0000-0003-0226-1047
Masood Kamali-MoghaddamDepartment of Immunology, Genetics & Pathology, Science for Life Laboratory, Uppsala University, SE-751 08 Uppsala, Sweden.
Gunilla EnbladExperimental and Clinical Oncology, Department of Immunology, Genetics and Pathology, Uppsala University, SE-752 36 Uppsala, Sweden.
Uppsala University · SE

Funding

Swedish Cancer Society 201147PjF
6 · The paper itself

Abstract

In classical Hodgkin Lymphoma (cHL), immunoediting via protein signaling is key to evading tumor surveillance. We aimed to identify immune-related proteins that distinguish diagnostic cHL tissues (=diagnostic tumor lysates,

Indexed as

biomarkersHodgkin lymphomaImmunologyLAG3 CCL17PD-L1proteomicsproximity assaystumor microenvironment

Identifiers

PMID35008176
PMCPMC8750205
OpenAlexW4200173668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.